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WARFARIN administered to tumour-
bearing mice reduces the number of spon-
taneous lung metastases (Hilgard et al.,
1977). The mechanism ofthis phenomenon
is not yet fully understood, but we have
shown that it is probably unrelated to the
induced coagulopathy (Hilgard & Maat,
1979). Administration of the drug and
simultaneous restoration of the depleted
coagulation factors II, VII, IX and X,
still significantly lowered the numbers of
lung metastases. On the other hand, a
stimulatory effect of coumarin and related
compounds on macrophages has been
described (Piller, 1977). Recently it has
been shown that the coumarin derivative
warfarin also increases in vivo macrophage
activity (von Melcher & Hilgard, sub-
mitted for publication).
These data support the hypothesis that
the antitumour effect of coumarin deriva-
tives might be mediated by stimulation of
the RES. To test this, it has been in-
vestigated whether substances with a
blocking effect on macrophages thus in-
hibit the warfarin-induced reduction of
tumour-colony formation in the lungs.
Among those substances are the seaweed
extract carrageenan (a sulphated galactan
ofhigh molecular weight) and silica. Both
have a number of immuno-suppressive
properties, including inactivation of mac-
rophages (Allison et al., 1966; Ishizaka
et at., 1977). In the present study the
effects of carrageenan and silica on war-
farin-induced reduction of lung metas-
tasis were investigated with 2 different
tumours.
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Since certain effects of carrageenan on
blood coagulation have been described in
the literature (Anderson & Duncan, 1965;
Thomson & Horne, 1976) coagulation para-
meters were also studied.
Groups of 10-15 C57BL/Rij male mice
were injected s.c. with 106 viable tumour
cells (Lewis lung carcinoma or B-16
melanoma). Warfarin administration was
begun on the day oftumour transplant by
i.p. injection of 2-5 mg/kg, and followed
by a daily oral dose in the drinking water,
till the end of the experiment.
Anticoagulation was monitored by the
thrombo-test assay. The dose of warfarin
was selected so as to keep the thrombo-test
values ofthe treated animals 2-5 x normal.
Iota carrageenan (type V, Sigma) was
given on Days 0, 5 and 10, as an i.p.
injection of 0 5 mg/mouse dissolved in
physiologic saline, sterilized by auto-
claving for 10 min at 15 lb/in2. A regimen
was chosen which was found to be effective
in mice by Ishizaka et al. (1977). Silica
(particle diam <5 ,um, Dr Reisner,
Steinkohlen-Bergbau Verein, Essen, Ger-
many) was injected i.p. at a dose of 25 mg/
mouse, dissolved in physiologic saline, on
Days 0 and 5.
Animals were killed at Day 23 (Lewis
lung carcinoma) or Day 28 (B-16 mela-
noma) by carbon-dioxide breathing. Lungs
were taken out by Wexler's method (Wex-
ler, 1965)* and fixed in either Bouin
solution for Lewis lung or Teliesniczi's
fixative for B-16 melanoma. After some
days fixation the macroscopic metastases
were counted.
* Lungs from animals with B-16 melanoma were filled with saline instead of Indian ink.B. MAAT
The thrombo-test values of animals
receiving warfarin were stable during the
course of the experiments, at a level of
2-5 x normal. Those of animals receiving
carrageenan or silica remained in the
same range as untreated control animals.
Treatment with carrageenan or silica
combined with warfarin gave the same
range of thrombo-test values as those in
the warfarin groups. There were no deaths
from overdose of anticoagulant.
The levels of fibrinogen degradation
products in serum of carrageenan-treated
mice were not increased.
In the animals receiving carrageenan
alone (Table I) there was an increase in
lung metastases over the controls. The
warfarin-treated mice showedtheexpected
drop in lung metastases, but a significant
increase to normal values was again seen
in animals receiving carrageenan in addi-
tion to the warfarin regimen.
Silica (Table II) alone was not followed
by an increase of lung metastases, but
silica added to warfarin gave a significant
increase in lung metastases over warfarin
alone. The results of experiments with
Lewis lung carcinoma did not differ from
those with B-16 melanoma (Table III).
The fact that the number ofmetastases in
the B-16 control groups is generally some-
what lower than those in the Lewis lung-
bearing animals is a common phenomenon,
and presumably due to tumour-specific
properties.
In the search for the fundamental
TABLE II.-Average numbers of lung
metastases (± s.e.) in mice bearing Lewis
lung carcinoma, treated with silica (Si)
and/or warfarin (Warf)
No. No. lung
animals metastaseQ
Exp. I
Control
Si
Warf+Si
Warf
Exp. II
Control
Si
Warf+ Si
Warf
14
11
12
13
15
10
10
14
7-3 + 1-2
6*2+ 1-2
5-2+0S8
3@7+0B5
9 5 + 0 7
6-3+ 1-6
6*2 + 1.8
3-5+0*5
g P
} N.S.
< <005
T N.S.
<0-05
N.S. =not significant.
mechanism for the antimetastatic effect of
coumarin derivatives, the major accent
has been put on their anticoagulative
properties. In the past it has been shown
by many researchers that the fate of
circulating tumour cells could be influ-
enced by the coagulability of the blood;
an increased clotting capacity was asso-
ciated with an increase in metastases,
whereas impaired clotting resulted in a
decrease (Wood & Strauli, 1973). These
effects were not only observed with i.v.
introduced tumour cells, but also with
primary metastasising tumours. Factors
modifying tumour-cell arrest were unduly
associated with antifibrin activity, since
fibrin was supposed to play an important
role in the attachment of tumour cells to
the vascular wall, thus initiating metas-
TABLE I.-Average numbers of lung metas-
tases (+ s.e.) in mice bearing Lewis lung
carcinoma, treated with carrageenan
(Carr) and/or warfarin (Warf)
Exp. 1
Control
Carr
Warf+Carr
Warf
Exp. II
Control
Carr
Warf+Carr
Warf
No. No. lung
animals metastases
15
12
12
14
14
10
12
13
p
19*3+12 f 0001
3 9+06} < 0*001
1732+-142 <0-001
1058_08 <0.001
TABLE III.-Average numbers of lung
metastases (+ s.e.) in mice bearing B-16
melanoma, treated with carrageenan
(Carr), silica (Si) and/or warfarin
(Warf)
Treatment
1. Control
2. Carr
3. Warf+Carr
4. Si
5. Warf+Si
6. Warf
No.
animals
15
13
14
14
12
15
No. lung
metastases
5-7+0.9
10-0+ 1-3
8-0+0-9
6-2+ 1.1
6-2+ 1*2
1.1+0-3
Significance: P<0.01; 3-6
P<0-05; 1-2, 1-6, 5-6
NS: 1-4, 2-3, 4-5.
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tatic growth (Chew & Wallace, 1976;
Maat & Hilgard, submitted).
Only recently, we have been able to
show that warfarin administration to mice,
followed by reconstitution of the blood
clotting capacity, still significantly de-
creased the number of lung colonies by an
amount equal to that seen after warfarin
treatment alone (Hilgard & Maat, 1979).
These findings were suggestive for an
explanation of the major effects in a dif-
ferent direction.
Since this antitumour effect was not
mediated by any coagulation factor, one
could question which other property of
coumarin derivatives might play a role.
Benzopyrones, including coumarin and
warfarin, have been shown to stimulate
macrophage activity. About 15 years ago
Kovach et al. (1965) showed that coumarin
(5-6-benzo-o-pyrone) enhanced the carbon
clearance of the blood. Later Piller
(1976b, c, d; 1977; 1978) and Dunn et al.
(1977) found that coumarin administration
enhanced phagocytosis by macrophages.
The actual mechanism of this pheno-
menon, however, is still uncertain. It
might be mediated by an increased lysis
of proteins by macrophages, since in
lymphoedenma the amount of accumulated
protein is considerably reduced after
administration of benzopyrones (Casley-
Smith, 1976). Destruction of macrophages
by treatment with silica completely
abolishes this effect (Casley-Smith et al.,
1978; Piller, 1976a). The total number of
macrophages is also increased by ad-
ministration of benzopyrones, including
coumarin (Piller, 1]978).
Recently, wvarfarin has been shown to
increase in vivo thioglycollate-stimulated
pinocytosis in mice (Melchner & Hilgard,
submitted for publication). Neither the
humoral immune response nor the T-cell
activity of mice seem to be affected by
warfarin (Berkarda et al., 1978). Undoubt-
edly, macrophages are a major factor in
the host's defence against tumour cells
(Alexander, 1974). Stimulation of this
defence is likely to increase antitumour
activity, as in warfarin-treated tumour-
bearing animals. If macrophage stimula-
tionis the actual cause ofdecreased metas-
tasis, a substance which selectively blocks
macrophage activity is likely to abolish
the effect.
In the present study both carrageenan
and silica restore the number ofmetastases
in warfarin-treated tumour-bearing ani-
mals to control levels. Carrageenan alone
raises the number oflung metastases above
the control levels, which could partially
be due to immune suppression. Apart from
carrageenan's selective toxicity for macro-
phages (Allison et al., 1966; Nelson &
Nelson, 1978; Fowler & Thomson, 1978;
Ishizaka et al., 1977) it has also been
shown to potentiate tumour growth
(Thomson & Fowler, 1977; Keller, 1976;
Lotzova & Richie, 1977). Since it has been
shown to be non-cytotoxic to lymphocytes
per se (Catanzaro et al., 1971) and does
not impair T-cell responses to PHA (Lake
et al., 1971) one may conclude that the
actual mechanism is impairment ofmacro-
phageactivity againsttumourgrowth. This
might be mediated by the carrageenan-
induced release of lysosomal enzymes in
macrophages.
The effect of silica is not so strong; the
number of lung metastases is unchanged
compared with controls. Nelson & Nelson
(1978) also failed to demonstrate immuno-
suppressive properties of silica, or any
effect on growth of tumours in mice. Yet
it can reverse the warfarin-induced macro-
phage stimulation.
No effect of carrageenan on blood
coagulation capacity could be found in
this study. If carrageenan did have an
anticoagulant activity, as has been des-
cribed by Anderson & Duncan (1965) in
rabbits after i.v. injection, this certainly
would not increase the number of metas-
tases, since heparin drastically reduces
the number of lung colonies after i.v.
injection of tumour cells (Maat, 1978) and
has no effect on metastasis in tumour-
bearing animals (Maat & Hilgard, sub-
mitted for publication). Disseminated
intravascular coagulation due to carra-
geenan has been described by Thomson &
315316 B. MAAT
Horne (1976) but does not seem to occur
with iota-carrageenan (Thomson et al.,
1976). Any signs of disseminated intra-
vascular coagulation, moreover, were not
observed at the dose of carrageenan used
in our experiments, since the serum level
offibrinogen degradation products was not
increased.
In conclusion, both macrophage inhibi-
tors silica and carrageenan abolish the
warfarin-induced decrease tumour metas-
tasis, which strongly supports the concept
that the antitumour effect of coumarin
derivatives is mediated by stimulation of
macrophages. The results do not seem to
beinfluenced by (anyeffects ofcarrageenan
on blood-coagulation factors.
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